Xopenex Inhalation (Levalbuterol Hydrochloride Inhalation) - Summary

SUMMARY

Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selective beta₂-adrenergic receptor agonist.

Xopenex (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

NEWS HIGHLIGHTS RELATED TO XOPENEX INHALATION

Published Studies Related to Xopenex Inhalation (Levalbuterol Inhalation)

Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]

Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]

An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]

Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]

Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]

more>>

Clinical Trials Related to Xopenex Inhalation (Levalbuterol Inhalation)

Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma [Completed]

Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD) [Completed]

Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients [Active, not recruiting]

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma [Completed]

Continuous Levalbuterol for Treatment of Status Asthmaticus in Children [Completed]

more>>